Reuters


Femara is the first drug approved for fighting cancer in post-menopausal women who have taken the drug tamoxifen for five years to keep the disease at bay.
In a Novartis-funded study, taking Femara after tamoxifen therapy cut the risk of death by 39 percent for certain breast cancer patients.

More...

Takeover of Indigenous Garifuna Community Hospital

Menstruation Is Fast Becoming Optional

Rare Disease Traced to Sperm Donor

Crohn's Disease Drug Cleared for Children

5-Month-Old Girls in ICU After Separation

Coroner: Peanut Kiss Didn't Cause Death

Feds Probe Kidney Transplant Program

Supermarkets Urge Families to Dinner Table